PSA Rapid Test Kit - Accurate & Efficient Diagnostic Tool by Tongzhou Biotechnology

Short Description:

The H-FABP Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human H-FABP in whole blood, serum or plasma as an aid in the diagnosis of acute myocardial infarction (AMI).

Place of Origin:China
Brand name:TZcheck


Product Detail

Product Tags

Introducing the revolutionary PSA Rapid Test by Tongzhou Biotechnology, an industry leader in producing high-quality diagnostic tools. Our PSA Rapid Test provides you with swift and accurate results, leading to prompt and effective treatment measures. It stands as a testament to our commitment towards driving advancements in the biotechnology sector. This cutting-edge PSA Rapid Test is designed to perform with high specificity, sensitivity, and accuracy, ensuring that medical professionals can wholly trust its results. We understand the crucial role that prompt and accurate diagnosis plays in medical treatment, and that is what our PSA Rapid Test aims to deliver. The PSA Rapid Test stands out in the market thanks to its unparalleled efficiency and precision. It has been developed under stringent quality control measures, reinforcing our reputation for producing top-notch biotechnological solutions. The PSA Rapid Test not only delivers timely results but also aids in minimizing the risk of diagnostic errors that could potentially lead to mismanaged treatment.

H-FABP Rapid Test

Cat. No.


Product Description

H-FABP Rapid Test





Kit Size

10 T


8 ng/mL



FABP is a newly introduced plasma marker of acute myocardial infarction (AMI). The plasma kinetics of FABP (15 kD) closely resemble those of myoglobin in that elevated plasma concentrations are found within 2 hours after AMI and return to normal generally within 18 to 24 hours. But the concentration of FABP in the skeletal muscle is 20 times lower than in cardiac tissue (for myoglobin the same content for cardiac and skeletal tissue), that makes FABP to be more cardiac specific than myoglobin. This makes FABP a useful biochemical marker for the early assessment or exclusion of AMI. FABP also appears to be a useful plasma marker for the estimation of myocardial infarct size. FABP is suitable for use as a standard in immunoassay for early detection of acute myocardial infarction, immunogen for antisera production, mass FABP standard, FABP biochemical and immunochemical studies, tracer for iodination.

Tongzhou Biotechnology's PSA Rapid Test heralds a new era of rapid diagnostic tests. This diagnostic tool's incorporation into medical facilities globally can streamline the process of patient testing considerably. The PSA Rapid Test proves to be incredibly beneficial in providing early diagnosis, thereby improving a patient's prognosis and paving the way for suitable and immediate treatment procedures. Invest in the PSA Rapid Test from Tongzhou Biotechnology – a breakthrough product that reflects our commitment to promoting better healthcare through advanced biotechnological solutions. Customers' trust in our products fuels our passion for continuous innovation in the field. Tongzhou Biotechnology strives to transform medical testing with our PSA Rapid Test kit, a crucial step towards faster and more reliable diagnosis. Experience the future of medical testing with our PSA Rapid Test today.

  • Previous:
  • Next:
  • Leave Your Message